Bay Street News, May, 2020

CAMBRIDGE, Mass., May 14, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target […]

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — Colliers International Group Inc. (NASDAQ and TSX: CIGI) (“Colliers”) announced today that it […]

RICHMOND HILL, Ontario, May 14, 2020 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology […]

WASHINGTON, May 14, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Jordan Rae Kelly, a Senior […]

DUBLIN, Ireland, May 14, 2020 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic […]

JOHANNESBURG, South Africa, May 14, 2020 (GLOBE NEWSWIRE) — Net 1 UEPS Technologies, Inc. (NasdaqGS: UEPS; JSE: NT1) (“Net1”) today […]

Company Expects to Initiate Phase 1/2 Clinical trial, in Collaboration with Bristol Myers Squibb, with CM-24 in Combination with nivolumab […]

New Drug Applications for Epsolay® and Twyneo® remain on track for the second quarter and second half 2020, respectivelyCompleted a […]

– Company has sufficient capital to advance pipeline and fund operations through 2021 –BOTHELL, WA, May 14, 2020 (GLOBE NEWSWIRE) […]

~ Substantial Presence with 22 Data Presentations Highlighting Breadth of Research, Technology and Manufacturing Platform ~~ New Non-Human Primate Data […]